HHTU News Roundup
3 new projects open in the Data Safe Haven
The Hull Health Trials Unit is responsible for the management of the University of Hull Data Safe Haven (DSH). The DSH is a trusted research environment that has the appropriate technical and information governance controls for the storage and processing of sensitive research data.
We currently have 18 projects active within the DSH, 3 of which were opened during August. We are currently enabling research across 3 of the 4 faculties at the University as well as with external collaborators based at the Hull University Teaching Hospitals (HUTH) and the York and Scarborough Teaching Hospitals NHS Foundation Trust (YSTH). This is with masters and PhD students as well as academics and clinicians.
The data being analysed in these projects is from 9 unique providers. The most common provider is NHS England. The DSH team are able to assist with applications for data and funding and have experience with NHS England, CPRD, UK Data Service amongst others. We also have 3 projects that are using the DSH for the storage and analysis of data collected during their own research study. This includes a study that is building a registry of palliative care data and another where app data was uploaded straight into the DSH for analysis.
The 3 studies that opened during August were HALO, PREDISPOSE HEME and DYNAMIC ROSE. You can find out more about these studies below:
HALO: This project is working with a team at HUTH who, under the leadership of Dr Anthony Maraveyas, are analysing the results of an international study. The study is about Thrombosis and bleeding in patients with thrombocytopenia in the HALO 109-301 trial for hyaluronan-high metastatic pancreatic ductal adenocarcinoma.
DYNAMIC ROSE: Is again working with a team at HUTH but with Dr Mike Crooks and his team. This study involves dynamic real world testing and evaluation: Implementing and evaluating the Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease (COPD) in HUTH. It is using data from HUTH and North Lincolnshire and Goole NHS Trust.
PREDISPOSE HEME: This study is using NHS England data to find out the prevalence of cirrhosis and its related complications amongst patients with hereditary haemochromatosis in England. Dr Rob Driver and his team at the YSTH are carrying out this study.
To learn more about the Data Safe Haven please visit the website. https://datasafehaven.hull.ac.uk/,
PRE-DX moves towards analysis
In other August news, PRE-DX reached another key point as the statistical analysis plan was signed off and all data queries were resolved allowing the study to go into data soft lock. Analysis will be completed over the remainder of 2024 with the results by early 2025.